Literature DB >> 23596275

The role of palliative care in the current HIV treatment era in developed countries.

Jessica S Merlins1, Rodney O Tucker, Michael S Saag, Peter A Selwyn.   

Abstract

The goal of palliative care is to minimize and prevent suffering and maximize physical function and quality of life in patients with serious illness. In the early years of the AIDS epidemic in developed countries, prognosis was poor and palliative care was often inseparable from HIV care. Despite the advent of effective antiretroviral therapy and its availability in developed countries, patients with HIV disease still present many palliative care challenges and opportunities. The cases of 3 HIV-infected patients who embody these challenges will be presented in this article: an older patient with numerous medical comorbidities, chronic pain, and severely impaired physical function; a patient with psychiatric illness and substance abuse, difficulties with adherence to antiretroviral therapy and retention in HIV primary care, and cryptococcal meningitis; and a patient with stable HIV disease and hepatitis C virus-related liver failure. These cases are being presented to stimulate a discussion between HIV and palliative care practitioners about potential areas of clinical and research collaboration.

Entities:  

Mesh:

Year:  2013        PMID: 23596275      PMCID: PMC6148889     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  48 in total

Review 1.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

2.  Clinical importance of provider-reported HIV symptoms compared with patient-report.

Authors:  A C Justice ; C H Chang ; L Rabeneck; R Zackin
Journal:  Med Care       Date:  2001-04       Impact factor: 2.983

3.  Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy.

Authors:  Fiona C Lampe; Richard Harding; Colette J Smith; Andrew N Phillips; Margaret Johnson; Lorraine Sherr
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

4.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Authors:  Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

5.  Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  J C Shlay; K Chaloner; M B Max; B Flaws; P Reichelderfer; D Wentworth; S Hillman; B Brizz; D L Cohn
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

6.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

7.  Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy.

Authors:  Gayle Newshan; JoAnne Bennett; Susan Holman
Journal:  J Assoc Nurses AIDS Care       Date:  2002 Jul-Aug       Impact factor: 1.354

8.  Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey.

Authors:  Aram Dobalian; Jennie C I Tsao; R Paul Duncan
Journal:  Med Care       Date:  2004-02       Impact factor: 2.983

9.  The comprehensive care team: a description of a controlled trial of care at the beginning of the end of life.

Authors:  Michael W Rabow; Jane Petersen; Karen Schanche; Suzanne L Dibble; Stephen J McPhee
Journal:  J Palliat Med       Date:  2003-06       Impact factor: 2.947

10.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.

Authors:  K Kieburtz; D Simpson; C Yiannoutsos; M B Max; C D Hall; R J Ellis; C M Marra; R McKendall; E Singer; G J Dal Pan; D B Clifford; T Tucker; B Cohen
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

View more
  6 in total

1.  Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.

Authors:  Jessica S Merlin; Ashutosh Tamhane; Joanna L Starrels; Stefan Kertesz; Michael Saag; Karen Cropsey
Journal:  AIDS Behav       Date:  2016-03

Review 2.  Pandemic palliative care: beyond ventilators and saving lives.

Authors:  Amit Arya; Sandy Buchman; Bruno Gagnon; James Downar
Journal:  CMAJ       Date:  2020-03-31       Impact factor: 8.262

3. 

Authors:  Amit Arya; Sandy Buchman; Bruno Gagnon; James Downar
Journal:  CMAJ       Date:  2020-10-19       Impact factor: 8.262

4.  Gender Differences and Psychosocial Factors Associated with Quality of Life Among ART Initiators in Oromia, Ethiopia.

Authors:  Quynh T Vo; Susie Hoffman; Denis Nash; Wafaa M El-Sadr; Olga A Tymejczyk; Tsigereda Gadisa; Zenebe Melaku; Sarah G Kulkarni; Robert H Remien; Batya Elul
Journal:  AIDS Behav       Date:  2016-08

5.  A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013.

Authors:  Claire E Kendall; Mathieu Chalifoux; Doug Manuel; Robert Reinhard; Gregory Robinson; Jean Bacon; Sean B Rourke; Ron Rosenes; Peter Tanuseputro
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

6.  Lived experiences of palliative care among people living with HIV/AIDS: a qualitative study from Bihar, India.

Authors:  Mohit Nair; Pragya Kumar; Raman Mahajan; Amit Harshana; Kathryn Richardson; Laura Moreto-Planas; Sakib Burza
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.